Education

UC Berkeley, AB, 12/2000, Molecular and Cell Biology
UC San Francisco, MD, 05/2006
UC San Francisco, Postdoctoral Fellow, 06/2011, Advanced Training in Clinical Research
UC San Francisco, Resident, 06/2013, General Surgery
UC San Francisco, Fellow, 06/2014, Breast Surgical Oncology

Honors & Awards

  • 2003
    Storer Scholarship, UCSF School of Medicine
  • 2005
    Student Research Award, Association for Academic Surgery
  • 2006
    Steinhart Scholarship, UCSF School of Medicine
  • 2007
    Dr Galante Scholarship Award, UCSF Department of Surgery
  • 2009
    Resident Research Scholarship, UCSF CTSI
  • 2013
    Teaching Award for Cherished Housestaff, UCSF School of Medicine
  • 2013
    Lawrence Way Critical Thinking Award, UCSF Department of Surgery

Selected Publications

  1. Galstyan A, Bunker MJ, Lobo F, Sims R, Inziello J, Stubbs J, Mukhtar R, Kelil T. Correction to: Applications of 3D printing in breast cancer management. 3D Print Med. 2021 Jul 07; 7(1):19.  View on PubMed
  2. Hewitt KC, Miller P, Piper M, Prionas N, Son JD, Alvarado M, Esserman LJ, Wong JM, Ewing C, Mukhtar RA. Positive margins after mastectomy in patients with invasive lobular carcinoma of the breast: Incidence and management strategies. Am J Surg. 2021 Jun 10.  View on PubMed
  3. Mary Kathryn Abel, Michelle E. Melisko, Hope S. Rugo, Amy Jo Chien, Italia Diaz, Julia K. Levine, Ann Griffin, Joseph McGuire, Laura Esserman, Hala Borno, Rita A. Mukhtar. Decreased enrollment of patients with advanced lobular breast cancer compared to ductal breast cancer in interventional clinical trials. Journal of Clinical Oncology. 2021 May 20; 39(15_suppl):1092-1092.  View on PubMed
  4. Im CJ, Miller A, Balassanian R, Mukhtar RA. Early onset, multiple, bilateral fibroadenomas of the breast: a case report. BMC Womens Health. 2021 04 21; 21(1):170.  View on PubMed
  5. Rita A. Mukhtar, A. Jo Chien. Invasive Lobular Carcinoma of the Breast: Ongoing Trials, Challenges, and Future Directions. Current Breast Cancer Reports. 2021 Apr 12; 1-7.  View on PubMed
  6. Harris HW, Primus F, Young C, Carter JT, Lin M, Mukhtar RA, Yeh B, Allen IE, Freise C, Kim E, Sbitany H, Young DM, Hansen S. Preventing Recurrence in Clean and Contaminated Hernias Using Biologic Versus Synthetic Mesh in Ventral Hernia Repair: The PRICE Randomized Clinical Trial. Ann Surg. 2021 04 01; 273(4):648-655.  View on PubMed
  7. Tang A, Cohan CM, Hansen KS, Beattie G, Greenwood HI, Mukhtar RA. Relationship between body mass index and malignancy rates of MRI-guided breast biopsies: impact of clinicodemographic factors. Breast Cancer Res Treat. 2021 Aug; 188(3):739-747.  View on PubMed
  8. Mukhtar RA, Boughey JC. ASO Author Reflections: Changes in Primary Treatment Strategy for Invasive Lobular Carcinoma Highlight the Need for Better Predictors of Therapy Response. Ann Surg Oncol. 2021 Mar 11.  View on PubMed
  9. Mukhtar RA, Hoskin TL, Habermann EB, Day CN, Boughey JC. Changes in Management Strategy and Impact of Neoadjuvant Therapy on Extent of Surgery in Invasive Lobular Carcinoma of the Breast: Analysis of the National Cancer Database (NCDB). Ann Surg Oncol. 2021 Mar 09.  View on PubMed
  10. Abel MK, Greenwood H, Kelil T, Guo R, Brabham C, Hylton N, Wong J, Alvarado M, Ewing C, Esserman LJ, Boughey JC, Mukhtar RA. Accuracy of breast MRI in evaluating nodal status after neoadjuvant therapy in invasive lobular carcinoma. NPJ Breast Cancer. 2021 Mar 05; 7(1):25.  View on PubMed
  11. Scheepens JCC, Veer LV', Esserman L, Belkora J, Mukhtar RA. Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability. Breast. 2021 Apr; 56:61-69.  View on PubMed
  12. Galstyan A, Bunker MJ, Lobo F, Sims R, Inziello J, Stubbs J, Mukhtar R, Kelil T. Applications of 3D printing in breast cancer management. 3D Print Med. 2021 Feb 09; 7(1):6.  View on PubMed
  13. Mukhtar RA, Brabham CE, Guo R, Abel MK, Wong J, Ewing C, Esserman LJ, Alvarado M. Accuracy of sentinel lymph node biopsy in invasive lobular carcinoma of the breast: Factors associated with false negatives. Breast J. 2021 04; 27(4):406-408.  View on PubMed
  14. Hansen KS, Ghersin H, Piper M, Tavakol M, Lee B, Esserman LJ, Roberts JP, Freise C, Ascher NL, Mukhtar RA. A world-wide survey on kidney transplantation practices in breast cancer survivors: The need for new management guidelines. Am J Transplant. 2021 Jan 09.  View on PubMed
  15. Northey JJ, Barrett AS, Acerbi I, Hayward MK, Talamantes S, Dean IS, Mouw JK, Ponik SM, Lakins JN, Huang PJ, Wu J, Shi Q, Samson S, Keely PJ, Mukhtar RA, Liphardt JT, Shepherd JA, Hwang ES, Chen YY, Hansen KC, Littlepage LE, Weaver VM. Stiff stroma increases breast cancer risk by inducing the oncogene ZNF217. J Clin Invest. 2020 11 02; 130(11):5721-5737.  View on PubMed
  16. Son JD, Piper M, Hewitt K, Alvarado M, Esserman LJ, Ewing C, Wong JM, Mukhtar RA. Oncological Outcomes of Total Skin-Sparing Mastectomy for Invasive Lobular Carcinoma of the Breast: A 20-Year Institutional Experience. Ann Surg Oncol. 2021 May; 28(5):2555-2560.  View on PubMed
  17. M.K. Abel, I. Diaz, J. Levine, L. Pate, E. Viggiano, M. Melisko, R. Mukhtar. 274 Poster Unintended bias in clinical trials: The prevalence of entry criteria that exclude patients with invasive lobular carcinoma from metastatic breast cancer trials. European Journal of Cancer. 2020 Oct 1; 138:s69-s70.  View on PubMed
  18. Abel MK, Fahrner-Scott K, Wong J, Alvarado M, Ewing C, Esserman LJ, Park C, Mukhtar RA. Evaluating the impact of axillary dissection on recurrence-free survival by extent of nodal disease in invasive lobular carcinoma of the breast. Breast Cancer Res Treat. 2020 Oct; 183(3):661-667.  View on PubMed
  19. Abel MK, Brabham CE, Guo R, Fahrner-Scott K, Wong J, Alvarado M, Ewing C, Esserman LJ, Mukhtar RA. Breast conservation therapy versus mastectomy in the surgical management of invasive lobular carcinoma measuring 4 cm or greater. Am J Surg. 2021 01; 221(1):32-36.  View on PubMed
  20. Jones EF, Hathi DK, Freimanis R, Mukhtar RA, Chien AJ, Esserman LJ, Van't Veer LJ, Joe BN, Hylton NM. Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy. Cancers (Basel). 2020 Jun 09; 12(6).  View on PubMed

Go to UCSF Profiles, powered by CTSI